Početna › Rak rektuma › Illinois
Kliničke studije za Rak rektuma u državi Illinois
12 studija za Rak rektuma traži sudionike na lokacijama u državi Illinois.
Gradovi u državi Illinois
- Chicago8 studija
- Waukegan3 studija
- Aurora3 studija
- Danville3 studija
- Champaign3 studija
- Charleston3 studija
- Naperville3 studija
Službeni tekst studije (engleski)
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- OSF Saint Anthony's Health Center, Alton
- Illinois CancerCare-Bloomington, Bloomington
- Illinois CancerCare-Canton, Canton
- i još 31
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07283939Family Communications After Genetic Testing
- OSF Saint Anthony's Health Center, Alton
- Advocate Outpatient Center - Aurora, Aurora
- Advocate Good Shepherd Hospital, Barrington
- i još 46
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Endeavor Health ( Site 2027), Evanston
- Accellacare of Duly ( Site 2015), Lisle
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06997497PRE-ISPY Phase I/II Oncology Platform Program
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
- UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, New Lenox
- UChicago Medicine Orland Park, Orland Park
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT05868226Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- OSF Saint Anthony's Health Center, Alton
- John H Stroger Jr Hospital of Cook County, Chicago
- Loyola University Medical Center, Maywood
- i još 3
U tijeku regrutacija
Od 45 do 70 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT05080673Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- Rush-Copley Medical Center, Aurora
- Northwestern University, Chicago
- Carle at The Riverfront, Danville
- i još 6
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. srp 2026. · NCT06205485Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
- City of Hope at Illinois Chicago Downtown, Chicago
- City of Hope at Chicago, Zion
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. srp 2026. · NCT07595874Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
- The University of Chicago, Chicago
U tijeku regrutacija
Od 18 do 90 godina · Oba spola · Ažurirano 15. lip 2026. · NCT05943210A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Illinois Cancer Specialists, Arlington Heights
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 12. lip 2026. · NCT07011576Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
- Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 do 49 godina · Oba spola · Ažurirano 24. tra 2026. · NCT05732623SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chicago
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.